Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 6/20 | 0.55 |
| ▸ | APLNR | P35414 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL645464 | 0.92 | HSP90AA1 (0.58) | HSP90AA1APLNRESR1MAPTTSHR | |
| SCHEMBL4940684 | 0.91 | HSP90AA1 (0.53) | HSP90AA1APLNRMAPTTSHRALDH1A1 | |
| SCHEMBL4941779 | 0.90 | HSP90AA1 (0.52) | HSP90AA1APLNRESR1MAPTTSHR | |
| SCHEMBL4937144 | 0.90 | HSP90AA1 (0.53) | HSP90AA1APLNRESR1MAPTNOTUM | |
| SCHEMBL4939580 | 0.89 | HSP90AA1 (0.58) | HSP90AA1MAPTNOTUMALDH1A1GAA | |
| SCHEMBL646966 | 0.89 | HSP90AA1 (0.52) | HSP90AA1MAPTALDH1A1LMNA | |
| SCHEMBL646642 | 0.89 | HSP90AA1 (0.52) | HSP90AA1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL4939553 | 0.88 | HSP90AA1 (0.70) | HSP90AA1APLNRMAPTNOTUMALDH1A1 | |
| SCHEMBL646667 | 0.88 | HSP90AA1 (0.51) | HSP90AA1MAPTTSHRALDH1A1LMNA | |
| SCHEMBL646372 | 0.87 | HSP90AA1 (0.50) | HSP90AA1ALDH1A1LMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8618285-B2 | Triazole derivatives | MERCK PATENT GMBH (DE) | 2013-12-31 | — | — | US | claimed |
| EP-1853570-B1 | HSP90-INHIBITING TRIAZOLE DERIVATIVES | MERCK PATENT GMBH (DE) | 2012-10-24 | — | — | EP | claimed |
| US-20080182857-A1 | Triazole Derivatives | MERCK PATENT GMBH (DE) | 2008-07-31 | — | — | US | claimed |
| CN-101119978-A | HSP90-inhibiting triazole derivatives | MERCK PATENT GMBH (DE) | 2008-02-06 | — | — | CN | claimed |
| US-8618285-B2 | Triazole derivatives | MERCK PATENT GMBH (DE) | 2013-12-31 | — | — | US | disclosed |
| EP-1853570-B1 | HSP90-INHIBITING TRIAZOLE DERIVATIVES | MERCK PATENT GMBH (DE) | 2012-10-24 | — | — | EP | disclosed |
| CN-101119978-B | HSP 90-inhibiting triazole derivatives | MERCK PATENT GMBH | 2012-05-23 | — | — | CN | disclosed |
| US-20080182857-A1 | Triazole Derivatives | MERCK PATENT GMBH (DE) | 2008-07-31 | — | — | US | disclosed |
| CN-101119978-A | HSP90-inhibiting triazole derivatives | MERCK PATENT GMBH (DE) | 2008-02-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080182857-A1 | Triazole Derivatives | HSP90AB1, HSP90AA1, HSP90B1 | HSP90AA1 2/4885APLNR 4865/4885ESR1 2460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.